Articles related to ADVERSE EVENTS

Interim results from J&J’s Phase I study of JNJ-6420 highlight both promising efficacy in prostate cancer treatment and serious safety concerns, with 60% of patients experiencing severe adverse events.

A case of pacemaker-lead dislodgement with cardiac perforation in a 96-year-old patient highlights the importance of recognizing and addressing complications swiftly to prevent severe outcomes.

Patients on GLP-1 medications may experience notable changes in breast morphology, such as decreased volume and increased sagging. Medical experts recommend supportive measures and a stable weight before considering surgical interventions.

Recent studies highlight that while meditation is beneficial for many, it can also lead to significant mental health challenges, including anxiety, psychosis, and depersonalization, particularly in intense meditative practices.

Recent studies suggest that GLP-1 receptor agonists, while primarily used for weight loss, may also impact mental health and behavior, potentially due to their effects on the brain’s reward systems.

In elderly patients, the heightened sensitivity to medications necessitates a tailored approach to prescribing, focusing on minimizing risks of confusion, hypotension, and falls. Consideration of safer alternatives and non-pharmacologic interventions is essential in promoting their well-being.